This study is testing a new imaging agent called FNP-59. FNP-59 is a "radiotracer" (a substance that helps show things on scans) designed to improve how we see cholesterol in the adrenal glands using a PET/CT scan. Researchers want to see if FNP-59 can be used safely and effectively to image the adrenal gland in healthy people. The main goal is to measure how much FNP-59 is taken up by your adrenal glands. You might be able to join if you are an adult (18 or older), do not have adrenal problems, are not pregnant, and are not taking certain medications like steroids or oral contraceptives. The current status of this study is unclear.

Study design

This is an interventional study, meaning participants will receive an intervention. It plans to enroll 6 healthy volunteers.

What's involved

You would receive FNP-59 for PET/CT scans. The primary measurement of FNP-59 uptake in your adrenal glands will be taken on Day 0.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint is measured at Day 0, which suggests a short follow-up period.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.